In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 8-K | 10-K | 10-K | 10-K |
Revenues: |
University partnerships segment | 232.8 | 376.2 | 407.6 | | | | | |
Growth segment | 30.2 | 20.9 | 10.2 | | | | | |
Total revenues | 263.0 | 397.1 | 417.8 | 443.4 | 443.4 | 475.1 | 523.5 | 561.7 |
Revenue growth [+] | -33.8% | -4.9% | -5.8% | -6.7% | | -9.2% | -6.8% | -12.1% |
University partnerships segment | -38.1% | -7.7% | | | | | | |
Growth segment | 44.7% | 104.9% | | | | | | |
Cost of goods sold | 162.1 | 297.2 | 300.1 | 217.7 | 217.7 | 235.4 | 263.3 | 281.5 |
Gross profit | 101.0 | 100.0 | 117.7 | 225.7 | 225.7 | 239.7 | 260.2 | 280.2 |
Gross margin | 38.4% | 25.2% | 28.2% | 50.9% | 50.9% | 50.5% | 49.7% | 49.9% |
Selling, general and administrative [+] | 128.5 | 139.0 | 152.8 | 221.7 | 53.0 | 222.8 | 251.0 | 254.2 |
Sales and marketing | 85.3 | 91.6 | 96.0 | 168.8 | | 175.4 | 202.2 | 197.6 |
General and administrative | 43.2 | 47.4 | 56.8 | 53.0 | 53.0 | 47.4 | 48.8 | 56.6 |
Other operating expenses | 9.8 | 13.2 | | 0.1 | 168.8 | 1.8 | 33.1 | 68.4 |
EBITDA [+] | -29.0 | -40.8 | -24.9 | 10.6 | 10.7 | 24.0 | -10.9 | -22.7 |
EBITDA growth | -29.0% | 63.9% | -335.2% | -55.8% | | -320.4% | -52.1% | -160.4% |
EBITDA margin | -11.0% | -10.3% | -6.0% | 2.4% | 2.4% | 5.0% | -2.1% | -4.0% |
Depreciation | 5.3 | 6.2 | 5.6 | 4.3 | 6.8 | 5.5 | 8.4 | 13.9 |
EBITA | -34.3 | -47.0 | -30.5 | 6.3 | 3.9 | 18.5 | -19.3 | -36.6 |
EBITA margin | -13.1% | -11.8% | -7.3% | 1.4% | 0.9% | 3.9% | -3.7% | -6.5% |
Amortization of intangibles | 3.0 | 5.2 | 4.6 | 2.5 | | 3.4 | 4.7 | 5.7 |
EBIT [+] | -37.3 | -52.2 | -35.1 | 3.8 | 3.9 | 15.1 | -24.0 | -42.3 |
EBIT growth | -28.5% | 48.6% | -1024.3% | -74.8% | | -163.1% | -43.4% | -395.5% |
EBIT margin | -14.2% | -13.1% | -8.4% | 0.9% | 0.9% | 3.2% | -4.6% | -7.5% |
Non-recurring items [+] | 5.3 | 9.7 | 21.5 | 7.8 | 7.9 | 8.7 | 19.3 | |
Asset impairment | 2.6 | 4.8 | | | | | | |
Legal settlement | | | | | 0.1 | | | |
Interest expense | | | | | | | | |
Interest expense | 3.1 | | | | | | | |
Other income (expense), net [+] | 3.2 | -0.1 | 1.0 | 1.0 | 1.0 | 1.5 | 2.3 | 2.1 |
Litigation settlement | 14.3 | | | 0.1 | | 1.8 | 33.1 | |
Other | 0.1 | -0.1 | 1.0 | 1.0 | 1.0 | 1.5 | 2.3 | 2.1 |
Pre-tax income | -42.5 | -62.0 | -55.6 | -2.9 | -2.9 | 7.9 | -40.9 | -40.2 |
Income taxes | -0.1 | -13.1 | -0.8 | -7.6 | -7.6 | -1.2 | -7.9 | 30.3 |
Tax rate | 0.3% | 21.1% | 1.4% | 257.4% | 257.4% | | 19.2% | |
Net income | -42.3 | -49.0 | -54.8 | 4.6 | 4.6 | 9.1 | -33.1 | -70.5 |
Net margin | -16.1% | -12.3% | -13.1% | 1.0% | 1.0% | 1.9% | -6.3% | -12.5% |
|
Basic EPS [+] | ($1.27) | ($1.53) | ($1.86) | $0.17 | $0.17 | $0.28 | ($0.71) | ($1.54) |
Growth | -16.9% | -17.6% | -1187.8% | -39.9% | | -139.8% | -53.7% | -821.4% |
Diluted EPS [+] | ($1.27) | ($1.53) | ($1.86) | $0.17 | $0.17 | $0.28 | ($0.71) | ($1.54) |
Growth | -16.9% | -17.6% | -1205.0% | -39.5% | | -138.9% | -53.7% | -842.3% |
|
Shares outstanding (basic) [+] | 33.3 | 32.0 | 29.5 | 27.1 | 27.1 | 32.1 | 46.2 | 45.7 |
Growth | 4.1% | 8.4% | 8.7% | -15.4% | | -30.7% | 1.2% | 1.0% |
Shares outstanding (diluted) [+] | 33.3 | 32.0 | 29.5 | 27.6 | 27.6 | 32.8 | 46.2 | 45.7 |
Growth | 4.1% | 8.4% | 7.0% | -16.0% | | -29.1% | 1.2% | -1.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |